ABEO
Abeona Therapeutics Inc.
NASDAQ · USHealthcareBiotechnology
$6.48-7.43%
Price as of Jul 20, 2026
ABEO valuation
Abeona Therapeutics Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 27.77x
- P/E 2026E
- —
- P/E 2027E
- 10.86x
- P/E 2028E
- 5.47x
- P/S forward
- 2.62x
Trailing multiples
- P/E TTM
- 5.04x
- PEG TTM
- —
- Price / book
- 2.55x
- Price / sales
- 25.40x
- Price / cash flow
- -4.75x
Enterprise value
- Enterprise value
- $224.2M
- EV / sales
- 15.42x
- EV / EBITDA
- 3.05x
- EV / EBIT
- -2.42x
- Market cap
- $369.3M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.